Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

New HC-PTP inhibitors and their use as wound-healing agents claimed by Ontogen

Nov. 6, 2003

New cytochrome P-450RAI inhibitors and their use patented by Allergan

Nov. 4, 2003

Encouraging preliminary phase II results for LyphoDerm

Oct. 31, 2003

Raptiva approved for chronic, moderate to severe plaque psoriasis

Oct. 30, 2003

First North American trial of Adhibit

Oct. 30, 2003

Daivobet effective in severe psoriasis

Oct. 29, 2003

Dual role of adenosine A2A receptor activation in wound healing

Oct. 29, 2003

Teva to commercialize OrCel in Israel

Oct. 28, 2003

Alefacept therapy beneficial in the treatment of psoriasis

Oct. 28, 2003

Polyphenon E (EGCg) improves preaged and damaged facial skin

Oct. 28, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...